(Q47214454)

11 January 2018

meta-analysis

0 references

title

Cognitive therapy for psychosis in schizophrenia: an effect size analysis. (English)

1 reference

11 January 2018

0 references

1 reference

R A Gould

1

1 reference

11 January 2018

K T Mueser

2

1 reference

11 January 2018

E Bolton

3

1 reference

11 January 2018

V Mays

4

1 reference

11 January 2018

D Goff

5

1 reference

11 January 2018

language of work or name

English

0 references

publication date

1 March 2001

1 reference

11 January 2018

published in

Schizophrenia Research

1 reference

11 January 2018

volume

48

1 reference

11 January 2018

page(s)

335-342

1 reference

11 January 2018

issue

2-3

1 reference

11 January 2018

A comprehensive psychopathological rating scale

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

An analysis of social competence in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

A latent structure analysis of the positive and negative symptoms in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

Acting on Delusions. II: The Phenomenological Correlates of Acting on Delusions

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

1 reference

7 January 2021

Psychiatric morbidity of a long stay hospital population with chronic schizophrenia and implications for future community care

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

Technique for training schizophrenic patients in illness self-management: a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

Cognitive behavioural therapy for drug-resistant psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. II: Predictors of outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

Individual cognitive-behavior therapy in the treatment of hallucinations and delusions: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

Psychopharmacologic treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

A standardized psychiatric assessment scale for rating chronic psychotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. I: effects of the treatment phase

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

London-east Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. III: Follow-up and economic evaluation at 18 months

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

Covert oral behavior and auditory hallucinations.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

Confrontation vs. belief modification in persistently deluded patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

Assessment of Enduring Deficit and Negative Symptom Subtypes in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

Evaluation of long-term therapeutic efficacy of behavior modification program with chronic male psychiatric inpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

An investigation of residual psychotic symptoms in discharged schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

A trial of two cognitive-behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: I. Outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

Durability of the effects of cognitive-behavioural therapy in the treatment of chronic schizophrenia: 12-month follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

Social skills training with schizophrenics: a meta-analytic evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

Defective interhemispheric transfer in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900145-6

7 January 2021

10.1016/S0920-9964(00)00145-6

Identifiers

DOI

1 reference

11 January 2018

PubMed ID

11295385

1 reference

11 January 2018